Engineering tumors: A tissue engineering perspective in cancer biology

Tissue Engineering - Part B: Reviews

Volumn 16, Issue 3, 2010, Pages 351-359

  Burdett, Emily ^a   Kasper, F Kurtis ^a   Mikos, Antonios G ^a   Ludwig, Joseph A ^b  

^a Rice University   (United States)

^b Department of Sarcoma Medical Oncology Unit 450 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3D CULTURE; ANTICANCER DRUG; BIOMEDICAL SCIENCE; CANCER BIOLOGY; CELLULAR AGGREGATES; DRUG RESISTANCE; EX-VIVO; IN-VIVO; MONOLAYER CULTURE; REGENERATIVE MEDICINE; RESEARCH GROUPS; THREE-DIMENSIONAL (3D); TUMOR BIOLOGY; TUMOR MODELS;

BIOLOGY; MONOLAYERS; TISSUE CULTURE; TISSUE ENGINEERING; TUMORS;

THREE DIMENSIONAL;

ACCURACY; CANCER RESEARCH; CANCER RESISTANCE; CELL AGGREGATION; DISEASE MODEL; HISTOLOGY; HUMAN; IN VITRO STUDY; MONOLAYER CULTURE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; THREE DIMENSIONAL IMAGING; TISSUE CULTURE; TISSUE ENGINEERING; TUMOR SPHEROID; TUMOR XENOGRAFT;

ANIMALS; CELL BIOLOGY; CELL CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; GELS; HUMANS; NEOPLASMS; SPHEROIDS, CELLULAR; TISSUE EMBEDDING; TISSUE ENGINEERING;

EID: 77952932509     PISSN: 19373368     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.teb.2009.0676     Document Type: Review

References (103)

1. Langer, R., and Vacanti, J.P. Tissue engineering. Science 260, 920, 1993.
2. Kretlow, J.D., and Mikos, A.G. From material to tissue: biomaterial development, scaffold fabrication, and tissue engineering. Aiche J 54, 3048, 2008.
3. Place, E.S., Evans, N.D., and Stevens, M.M. Complexity in biomaterials for tissue engineering. Nat Mater 8, 457, 2009.
4. Griffith, L.G., and Swartz, M.A. Capturing complex 3d tissue physiology in vitro. Nat Rev Mol Cell Biol 7, 211, 2006.
5. Bissell, M.J., and Radisky, D. Putting tumours in context. Nat Rev Cancer 1, 46, 2001.
6. Jacks, T., and Weinberg, R.A. Taking the study of cancer cell survival to a new dimension. Cell 111, 923, 2002.
7. Mueller, M.M., and Fusenig, N.E. Friends or foes\bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4, 839, 2004.
8. Smalley, K.S., Lioni, M., and Herlyn, M. Life isn't flat: taking cancer biology to the next dimension. In Vitro Cell Dev Biol Anim 42, 242, 2006.
9. Kola, I., and Landis, J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3, 711, 2004.
10. Sawyers, C. Targeted cancer therapy. Nature 432, 294, 2004.
11. Haffner, M.E. Adopting orphan drugs\two dozen years of treating rare diseases. N Engl J Med 354, 445, 2006.
12. Wastfelt, M., Fadeel, B., and Henter, J.I. A journey of hope: lessons learned from studies on rare diseases and orphan drugs. J Intern Med 260, 1, 2006.
13. Subbiah, V., Anderson, P., Lazar, A.J., Burdett, E., Raymond, K., and Ludwig, J.A. Ewing's sarcoma: standard and experimental treatment options. Curr Treat Options Oncol 10, 126, 2009.
14. Ludwig, J.A. Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future. Curr Opin Oncol 20, 412, 2008.
15. Shoemaker, R.H. The nci60 human tumour cell line anti-cancer drug screen. Nat Rev Cancer 6, 813, 2006.
16. Holbeck, S.L. Update on nci in vitro drug screen utilities. Eur J Cancer 40, 785, 2004.
17. Monga, M., and Sausville, E.A. Developmental therapeutics program at the nci: molecular target and drug discovery process. Leukemia 16, 520, 2002.
18. Ertel, A., Verghese, A., Byers, S.W., Ochs, M., and Tozeren, A. Pathway-specific differences between tumor cell lines and normal and tumor tissue cells. Mol Cancer 5, 55, 2006.
19. Johnson, J.I., Decker, S., Zaharevitz, D., Rubinstein, L.V., Venditti, J.M., Schepartz, S., Kalyandrug, S., Christian, M., Arbuck, S., Hollingshead, M., and Sausville, E.A. Relationships between drug activity in nci preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 84, 1424, 2001.
20. Voskoglou-Nomikos, T., Pater, J.L., and Seymour, L. Clinical predictive value of the in vitro cell line, human xeno-graft, and mouse allograft preclinical cancer models. Clin Cancer Res 9, 4227, 2003.
21. van Staveren, W.C., Solis, D.Y., Hebrant, A., Detours, V., Dumont, J.E., and Maenhaut, C. Human cancer cell lines: experimental models for cancer cells in situ? For cancer stem cells? Biochim Biophys Acta 1795, 92, 2009.
22. Wernert, N. The multiple roles of tumour stroma. Virchows Arch 430, 433, 1997.
23. Liotta, L.A., and Kohn, E.C. The microenvironment of the tumour-host interface. Nature 411, 375, 2001.
24. Zahir, N., and Weaver, V.M. Death in the third dimension: apoptosis regulation and tissue architecture. Curr Opin Genet Dev 14, 71, 2004.
25. Bogdanos, J., Karamanolakis, D., Tenta, R., Tsintavis, A., Milathianakis, C., Mitsiades, C., and Koutsilieris, M. Endocrine=paracrine=autocrine survival factor activity of bone microenvironment participates in the development of androgen ablation and chemotherapy refractoriness of prostate cancer metastasis in skeleton. Endocr Relat Cancer 10, 279, 2003.
26. Morin, P.J. Drug resistance and the microenvironment: nature and nurture. Drug Resist Updat 6, 169, 2003.
27. Weaver, V.M., Lelievre, S., Lakins, J.N., Chrenek, M.A., Jones, J.C., Giancotti, F., Werb, Z., and Bissell, M.J. Beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2, 205, 2002.
28. Sethi, T., Rintoul, R.C., Moore, S.M., MacKinnon, A.C., Salter, D., Choo, C., Chilvers, E.R., Dransfield, I., Donnelly, S.C., Strieter, R., and Haslett, C. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 5, 662, 1999.
29. Rintoul, R.C., and Sethi, T. Extracellular matrix regulation of drug resistance in small-cell lung cancer. Clin Sci (Lond) 102, 417, 2002.
30. Damiano, J.S., Cress, A.E., Hazlehurst, L.A., Shtil, A.A., and Dalton, W.S. Cell adhesion mediated drug resistance (cam-dr): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood 93, 1658, 1999.
31. Kung, A.L. Practices and pitfalls of mouse cancer models in drug discovery. Adv Cancer Res 96, 191, 2007.
32. Teicher, B.A. Tumor models for efficacy determination. Mol Cancer Ther 5, 2435, 2006.
33. Kelland, L.R. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development. Eur J Cancer 40, 827, 2004.
34. Vormoor, J., Baersch, G., Decker, S., Hotfilder, M., Schafer, K.L., Pelken, L., Rube, C., Van Valen, F., Jurgens, H., and Dockhorn-Dworniczak, B. Establishment of an in vivo model for pediatric Ewing tumors by transplantation into nod=scid mice. Pediatr Res 49, 332, 2001.
35. Killion, J.J., Radinsky, R., and Fidler, I.J. Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev 17, 279, 1998.
36. Sharpless, N.E., and Depinho, R.A. The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 5, 741, 2006.
37. Talmadge, J.E., Lenz, B.F., Klabansky, R., Simon, R., Riggs, C., Guo, S., Oldham, R.K., and Fidler, I.J. Therapy of autochthonous skin cancers in mice with intravenously injected liposomes containing muramyltripeptide. Cancer Res 46, 1160, 1986.
38. Talmadge, J.E., Singh, R.K., Fidler, I.J., and Raz, A. Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol 170, 793, 2007.
39. Lawlor, E.R., Scheel, C., Irving, J., and Sorensen, P.H. Anchorage-independent multi-cellular spheroids as an in vitro model of growth signaling in ewing tumors. On-cogene 21, 307, 2002.
40. Myatt, S.S., Redfern, C.P., and Burchill, S.A. P38mapk-dependent sensitivity of Ewing's sarcoma family of tumors to fenretinide-induced cell death. Clin Cancer Res 11, 3136, 2005.
41. Lin, R.Z., and Chang, H.Y. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J 3, 1172, 2008.
42. Friedrich, J., Ebner, R., and Kunz-Schughart, L.A. Experimental anti-tumor therapy in 3-d: spheroids\old hat or new challenge? Int J Radiat Biol 83, 849, 2007.
43. Kunz-Schughart, L.A. Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor. Cell Biol Int 23, 157, 1999.
44. Bates, R.C., Edwards, N.S., and Yates, J.D. Spheroids and cell survival. Crit Rev Oncol Hematol 36, 61, 2000.
45. Mueller-Klieser, W. Multicellular spheroids. A review on cellular aggregates in cancer research. J Cancer Res Clin Oncol 113, 101, 1987.
46. Mueller-Klieser, W. Three-dimensional cell cultures: from molecular mechanisms to clinical applications. Am J Phy-siol 273, C1109, 1997.
47. Sutherland, R.M., Inch, W.R., McCredie, J.A., and Kruuv, J. A multi-component radiation survival curve using an in vitro tumour model. Int J Radiat Biol Relat Stud Phys Chem Med 18, 491, 1970.
48. Durand, R.E., and Sutherland, R.M. Effects of intercellular contact on repair of radiation damage. Exp Cell Res 71, 75, 1972.
49. Yuhas, J.M., Li, A.P., Martinez, A.O., and Ladman, A.J. A simplified method for production and growth of multicel-lular tumor spheroids. Cancer Res 37, 3639, 1977.
50. Friedrich, J., Seidel, C., Ebner, R., and Kunz-Schughart, L.A. Spheroid-based drug screen: considerations and practical approach. Nat Protoc 4, 309, 2009.
51. Timmins, N.E., and Nielsen, L.K. Generation of multicel-lular tumor spheroids by the hanging-drop method. Methods Mol Med 140, 141, 2007.
52. Wu, L.Y., Di Carlo, D., and Lee, L.P. Microfluidic self-assembly of tumor spheroids for anticancer drug discovery. Biomed Microdevices 10, 197, 2008.
53. Herrmann, R., Fayad, W., Schwarz, S., Berndtsson, M., and Linder, S. Screening for compounds that induce apoptosis of cancer cells grown as multicellular spheroids. J Biomol Screen 13, 1, 2008.
54. Kang, H.G., Jenabi, J.M., Zhang, J., Keshelava, N., Shimada, H., May, W.A., Ng, T., Reynolds, C.P., Triche, T.J., and Sorensen, P.H. E-cadherin cell-cell adhesion in Ewing tumor cells mediates suppression of anoikis through activation of the erbb4 tyrosine kinase. Cancer Res 67, 3094, 2007.
55. Hamilton, G. Multicellular spheroids as an in vitro tumor model. Cancer Lett 131, 29, 1998.
56. Graff, C.P., and Wittrup, K.D. Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retention. Cancer Res 63, 1288, 2003.
57. Ackerman, M.E., Pawlowski, D., and Wittrup, K.D. Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroids. Mol Cancer Ther 7, 2233, 2008.
58. Thurber, G.M., and Wittrup, K.D. Quantitative spatio-temporal analysis of antibody fragment diffusion and en-docytic consumption in tumor spheroids. Cancer Res 68, 3334, 2008.
59. Ng, K.W., Leong, D.T., and Hutmacher, D.W. The challenge to measure cell proliferation in two and three dimensions. Tissue Eng 11, 182, 2005.
60. Thielecke, H., Mack, A., and Robitzki, A. A multicellular spheroid-based sensor for anti-cancer therapeutics. Biosens Bioelectron 16, 261, 2001.
61. Reininger-Mack, A., Thielecke, H., and Robitzki, A.A. 3d-biohybrid systems: applications in drug screening. Trends Biotechnol 20, 56, 2002.
62. Hubbell, J.A. Biomaterials in tissue engineering. Biotechnology (N Y) 13, 565, 1995.
63. Freeman, A.E., and Hoffman, R.M. In vivo-like growth of human tumors in vitro. Proc Natl Acad Sci USA 83, 2694, 1986.
64. Sinha, D.K., and White, C.J. Collagen gel culture of rat mammary tumor cells as an assay system for determination of therapeutic efficacy of chemotherapeutic agents. In Vitro Cell Dev Biol 24, 525, 1988.
65. Vescio, R.A., Connors, K.M., Kubota, T., and Hoffman, R.M. Correlation of histology and drug response of human tumors grown in native-state three-dimensional histo-culture and in nude mice. Proc Natl Acad Sci USA 88, 5163, 1991.
66. Kubota, T., Sasano, N., Abe, O., Nakao, I., Kawamura, E., Saito, T., Endo, M., Kimura, K., Demura, H., and Sasano, H., Potential of the histoculture drug-response assay to contribute to cancer patient survival. Clin Cancer Res 1, 1537, 1995.
67. Takamura, Y., Kobayashi, H., Taguchi, T., Motomura, K., Inaji, H., and Noguchi, S. Prediction of chemotherapeutic response by collagen gel droplet embedded culture-drug sensitivity test in human breast cancers. Int J Cancer 98, 450, 2002.
68. Kawamura, M., Gika, M., Abiko, T., Inoue, Y., Oyama, T., Izumi, Y., Kobayashi, H., and Kobayashi, K. Clinical evaluation of chemosensitivity testing for patients with un-resectable non-small cell lung cancer (nsclc) using collagen gel droplet embedded culture drug sensitivity test (cd-dst). Cancer Chemother Pharmacol 59, 507, 2007.
69. Yang, J., Richards, J., Bowman, P., Guzman, R., Enami, J., McCormick, K., Hamamoto, S., Pitelka, D., and Nandi, S. Sustained growth and three-dimensional organization of primary mammary tumor epithelial cells embedded in collagen gels. Proc Natl Acad Sci USA 76, 3401, 1979.
70. Miller, B.E., Miller, F.R., and Heppner, G.H. Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures. Cancer Res 45, 4200, 1985.
71. Torisawa, Y.S., Shiku, H., Yasukawa, T., Nishizawa, M., and Matsue, T. Multi-channel 3-d cell culture device integrated on a silicon chip for anticancer drug sensitivity test. Biomaterials 26, 2165, 2005.
72. Xu, F., and Burg, K.J. Three-dimensional polymeric systems for cancer cell studies. Cytotechnology 54, 135, 2007.
73. O'Keane, J.C., Kupchik, H.Z., Schroy, P.C., Andry, C.D., Collins, E., and O'Brien, M.J. A three-dimensional system for long-term culture of human colorectal adenomas. Am J Pathol 137, 1539, 1990.
74. Kupchik, H.Z., Langer, R.S., Haberern, C., El Deriny, S., and O'Brien, M. A new method for the three-dimensional in vitro growth of human cancer cells. Exp Cell Res 147, 454, 1983.
75. Boxberger, H.J., and Meyer, T.F. A new method for the 3-d in vitro growth of human rt112 bladder carcinoma cells using the alginate culture technique. Biol Cell 82, 109, 1994.
76. Kupchik, H.Z., Collins, E.A., O'Brien, M.J., and McCaffrey, R.P. Chemotherapy screening assay using 3-dimensional cell culture. Cancer Lett 51, 11, 1990.
77. Zhang, X., Wang, W., Yu, W., Xie, Y., Zhang, Y., and Ma, X. Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in an-ticancer drug screening and testing. Biotechnol Prog 21, 1289, 2005.
78. Kleinman, H.K., and Martin, G.R. Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 15, 378, 2005.
79. Petersen, O.W., Ronnov-Jessen, L., Howlett, A.R., and Bis-sell, M.J. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci USA 89, 9064, 1992.
80. Webber, M.M., Bello, D., Kleinman, H.K., and Hoffman, M.P. Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells. Carcinogenesis 18, 1225, 1997.
81. Lee, G.Y., Kenny, P.A., Lee, E.H., and Bissell, M.J. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 4, 359, 2007.
82. Weaver, V.M., Petersen, O.W., Wang, F., Larabell, C.A., Briand, P., Damsky, C., and Bissell, M.J. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137, 231, 1997.
83. Wang, F., Weaver, V.M., Petersen, O.W., Larabell, C.A., Dedhar, S., Briand, P., Lupu, R., and Bissell, M.J. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci USA 95, 14821, 1998.
84. Zaman, M.H., Trapani, L.M., Sieminski, A.L., Mackellar, D., Gong, H., Kamm, R.D., Wells, A., Lauffenburger, D.A., and Matsudaira, P. Migration of tumor cells in 3d matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc Natl Acad Sci USA 103, 10889, 2006.
85. Uriel, S., Labay, E., Francis-Sedlak, M., Moya, M.L., Weichselbaum, R.R., Ervin, N., Cankova, Z., and Brey, E.M. Extraction and assembly of tissue-derived gels for cell culture and tissue engineering. Tissue Eng Part C Methods 15, 309, 2009.
86. Ramanujan, S., Pluen, A., McKee, T.D., Brown, E.B., Boucher, Y., and Jain, R.K. Diffusion and convection in collagen gels: implications for transport in the tumor interstitium. Biophys J 83, 1650, 2002.
87. Dhiman, H.K., Ray, A.R., and Panda, A.K. Characterization and evaluation of chitosan matrix for in vitro growth of mcf-7 breast cancer cell lines. Biomaterials 25, 5147, 2004.
88. Dhiman, H.K., Ray, A.R., and Panda, A.K. Three-dimensional chitosan scaffold-based mcf-7 cell culture for the determination of the cytotoxicity of tamoxifen. Bioma-terials 26, 979, 2005.
89. Sahoo, S.K., Panda, A.K., and Labhasetwar, V. Characterization of porous plga=pla microparticles as a scaffold for three dimensional growth of breast cancer cells. Bioma-cromolecules 6, 1132, 2005.
90. Horning, J.L., Sahoo, S.K., Vijayaraghavalu, S., Dimitrijevic, S., Vasir, J.K., Jain, T.K., Panda, A.K., and Labhasetwar, V. 3-d tumor model for in vitro evaluation of anticancer drugs. Mol Pharm 5, 849, 2008.
91. Fischbach, C., Chen, R., Matsumoto, T., Schmelzle, T., Brugge, J.S., Polverini, P.J., and Mooney, D.J. Engineering tumors with 3d scaffolds. Nat Methods 4, 855, 2007.
92. Shin, H., Jo, S., and Mikos, A.G. Biomimetic materials for tissue engineering. Biomaterials 24, 4353, 2003.
93. Folkman, J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29, 15, 2002.
94. Carmeliet, P., and Jain, R.K. Angiogenesis in cancer and other diseases. Nature 407, 249, 2000.
95. Martin, I., Wendt, D., and Heberer, M. The role of biore-actors in tissue engineering. Trends Biotechnol 22, 80, 2004.
96. Bancroft, G.N., Sikavitsas, V.I., and Mikos, A.G. Design of a flow perfusion bioreactor system for bone tissue-engineering applications. Tissue Eng 9, 549, 2003.
97. Ratcliffe, A., and Niklason, L.E. Bioreactors and bioproces-sing for tissue engineering. Ann N Y Acad Sci 961, 210, 2002.
98. Hendriks, J., Riesle, J., and van Blitterswijk, C.A. Co-culture in cartilage tissue engineering. J Tissue Eng Regen Med 1, 170, 2007.
99. Elenbaas, B., and Weinberg, R.A. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 264, 169, 2001.
100. Weinberg, R.A. Coevolution in the tumor microenviron-ment. Nat Genet 40, 494, 2008.
101. Kunz-Schughart, L.A., Heyder, P., Schroeder, J., and Knuechel, R. A heterologous 3-d coculture model of breast tumor cells and fibroblasts to study tumor-associated fi-broblast differentiation. Exp Cell Res 266, 74, 2001.
102. Hauptmann, S., Zwadlo-Klarwasser, G., Jansen, M., Klosterhalfen, B., and Kirkpatrick, C.J. Macrophages and multicellular tumor spheroids in co-culture: a three-dimensional model to study tumor-host interactions. Evidence for macrophage-mediated tumor cell proliferation and migration. Am J Pathol 143, 1406, 1993.
103. Wang, R., Xu, J., Juliette, L., Castilleja, A., Love, J., Sung, S.Y., Zhau, H.E., Goodwin, T.J., and Chung, L.W. Three-dimensional co-culture models to study prostate cancer growth, progression, and metastasis to bone. Semin Cancer Biol 15, 353, 2005.